Effect of Peginterferon or Ribavirin Dosing on Efficacy of Therapy With Telaprevir in Treatment-Experienced Patients With Chronic Hepatitis C and Advanced Liver Fibrosis

Ewa Janczewska, Robert Flisiak, Dorota Zarebska-Michaluk, Dorota Kozielewicz, Hanna Berak, Beata Dobracka, Marta Librant-Suska, Wladyslaw Lojewski, Krzysztof Jurczyk, Joanna Musialik, Barbara Postawa-Klosińska, Jacek Wroblewski, Krystyna Augustyniak, Marek Dudziak, Iwona Olszok, Agata Ruszala, Arkadiusz Pisula, Tadeusz Lapinski, Wieslaw Kryczka, Andrzej Horban, Witold Dobracki

Open source

DOI
10.1097/md.0000000000001411
Published
2015-09
Container
Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/md.0000000000001411,
  title = {Effect of Peginterferon or Ribavirin Dosing on Efficacy of Therapy With Telaprevir in Treatment-Experienced Patients With Chronic Hepatitis C and Advanced Liver Fibrosis},
  author = {Ewa Janczewska and Robert Flisiak and Dorota Zarebska-Michaluk and Dorota Kozielewicz and Hanna Berak and Beata Dobracka and Marta Librant-Suska and Wladyslaw Lojewski and Krzysztof Jurczyk and Joanna Musialik and Barbara Postawa-Klosińska and Jacek Wroblewski and Krystyna Augustyniak and Marek Dudziak and Iwona Olszok and Agata Ruszala and Arkadiusz Pisula and Tadeusz Lapinski and Wieslaw Kryczka and Andrzej Horban and Witold Dobracki},
  year = {2015},
  journal = {Medicine},
  doi = {10.1097/md.0000000000001411},
  url = {https://doi.org/10.1097/md.0000000000001411}
}

RIS

TY  - JOUR
TI  - Effect of Peginterferon or Ribavirin Dosing on Efficacy of Therapy With Telaprevir in Treatment-Experienced Patients With Chronic Hepatitis C and Advanced Liver Fibrosis
AU  - Ewa Janczewska
AU  - Robert Flisiak
AU  - Dorota Zarebska-Michaluk
AU  - Dorota Kozielewicz
AU  - Hanna Berak
AU  - Beata Dobracka
AU  - Marta Librant-Suska
AU  - Wladyslaw Lojewski
AU  - Krzysztof Jurczyk
AU  - Joanna Musialik
AU  - Barbara Postawa-Klosińska
AU  - Jacek Wroblewski
AU  - Krystyna Augustyniak
AU  - Marek Dudziak
AU  - Iwona Olszok
AU  - Agata Ruszala
AU  - Arkadiusz Pisula
AU  - Tadeusz Lapinski
AU  - Wieslaw Kryczka
AU  - Andrzej Horban
AU  - Witold Dobracki
PY  - 2015
JO  - Medicine
DO  - 10.1097/md.0000000000001411
UR  - https://doi.org/10.1097/md.0000000000001411
ER  - 

APA

Janczewska, E., Flisiak, R., Zarebska-Michaluk, D., Kozielewicz, D., Berak, H., Dobracka, B., Librant-Suska, M., Lojewski, W., Jurczyk, K., Musialik, J., Postawa-Klosińska, B., Wroblewski, J., Augustyniak, K., Dudziak, M., Olszok, I., Ruszala, A., Pisula, A., Lapinski, T., Kryczka, W., Horban, A., & Dobracki, W. (2015). Effect of Peginterferon or Ribavirin Dosing on Efficacy of Therapy With Telaprevir in Treatment-Experienced Patients With Chronic Hepatitis C and Advanced Liver Fibrosis. Medicine. https://doi.org/10.1097/md.0000000000001411

Source records